Literature DB >> 27297388

Murine Alveolar Macrophages Are Highly Susceptible to Replication of Coxiella burnetii Phase II In Vitro.

Talita D Fernandes1, Larissa D Cunha1, Juliana M Ribeiro1, Liliana M Massis1, Djalma S Lima-Junior1, Hayley J Newton2, Dario S Zamboni3.   

Abstract

Coxiella burnetii is a Gram-negative bacterium that causes Q fever in humans. Q fever is an atypical pneumonia transmitted through inhalation of contaminated aerosols. In mammalian lungs, C. burnetii infects and replicates in several cell types, including alveolar macrophages (AMs). The innate immunity and signaling pathways operating during infection are still poorly understood, in part because of the lack of relevant host cell models for infection in vitro In the study described here, we investigated and characterized the infection of primary murine AMs by C. burnetii phase II in vitro Our data reveal that AMs show a pronounced M2 polarization and are highly permissive to C. burnetii multiplication in vitro Murine AMs present an increased susceptibility to infection in comparison to primary bone marrow-derived macrophages. AMs support more than 2 logs of bacterial replication during 12 days of infection in culture, similar to highly susceptible host cells, such as Vero and THP-1 cells. As a proof of principle that AMs are useful for investigation of C. burnetii replication, we performed experiments with AMs from Nos2(-/-) or Ifng(-/-) mice. In the absence of gamma interferon and nitric oxide synthase 2 (NOS2), AMs were significantly more permissive than wild-type cells. In contrast, AMs from Il4(-/-) mice were more restrictive to C. burnetii replication, supporting the importance of M2 polarization for the permissiveness of AMs to C. burnetii replication. Collectively, our data account for understanding the high susceptibility of alveolar macrophages to bacterial replication and support the use of AMs as a relevant model of C. burnetii growth in primary macrophages.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27297388      PMCID: PMC4995897          DOI: 10.1128/IAI.00411-16

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

1.  Coxiella burnetii acid phosphatase inhibits the release of reactive oxygen intermediates in polymorphonuclear leukocytes.

Authors:  J Hill; J E Samuel
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

2.  Coxiella burnetii, the agent of Q fever, stimulates an atypical M2 activation program in human macrophages.

Authors:  Marie Benoit; Bernadette Barbarat; Alain Bernard; Daniel Olive; Jean-Louis Mege
Journal:  Eur J Immunol       Date:  2008-04       Impact factor: 5.532

3.  IFN-gamma-mediated control of Coxiella burnetii survival in monocytes: the role of cell apoptosis and TNF.

Authors:  J Dellacasagrande; C Capo; D Raoult; J L Mege
Journal:  J Immunol       Date:  1999-02-15       Impact factor: 5.422

4.  Virulent Coxiella burnetii pathotypes productively infect primary human alveolar macrophages.

Authors:  Joseph G Graham; Laura J MacDonald; S Kauser Hussain; Uma M Sharma; Richard C Kurten; Daniel E Voth
Journal:  Cell Microbiol       Date:  2013-01-14       Impact factor: 3.715

5.  Primary Role for Toll-Like Receptor-Driven Tumor Necrosis Factor Rather than Cytosolic Immune Detection in Restricting Coxiella burnetii Phase II Replication within Mouse Macrophages.

Authors:  William P Bradley; Mark A Boyer; Hieu T Nguyen; L Dillon Birdwell; Janet Yu; Juliana M Ribeiro; Susan R Weiss; Dario S Zamboni; Craig R Roy; Sunny Shin
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

6.  Both inducible nitric oxide synthase and NADPH oxidase contribute to the control of virulent phase I Coxiella burnetii infections.

Authors:  Robert E Brennan; Kasi Russell; Guoquan Zhang; James E Samuel
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

7.  Differential regulation of human blood monocyte and alveolar macrophage inflammatory cytokine production by nitric oxide.

Authors:  C Dinakar; A Malur; B Raychaudhuri; L T Buhrow; A L Melton; M S Kavuru; M J Thomassen
Journal:  Ann Allergy Asthma Immunol       Date:  1999-02       Impact factor: 6.347

8.  Genetic control of natural resistance of mouse macrophages to Coxiella burnetii infection in vitro: macrophages from restrictive strains control parasitophorous vacuole maturation.

Authors:  Dario S Zamboni
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

9.  Severely impaired health status of non-notified Q fever patients leads to an underestimation of the true burden of disease.

Authors:  J A F van Loenhout; C C H Wielders; G Morroy; M J M Cox; W van der Hoek; J L A Hautvast; W J Paget; J van der Velden
Journal:  Epidemiol Infect       Date:  2015-01-13       Impact factor: 4.434

10.  Dot/Icm type IVB secretion system requirements for Coxiella burnetii growth in human macrophages.

Authors:  Paul A Beare; Stacey D Gilk; Charles L Larson; Joshua Hill; Christopher M Stead; Anders Omsland; Diane C Cockrell; Dale Howe; Daniel E Voth; Robert A Heinzen
Journal:  mBio       Date:  2011-09-01       Impact factor: 7.867

View more
  11 in total

Review 1.  Coxiella burnetii: international pathogen of mystery.

Authors:  Amanda L Dragan; Daniel E Voth
Journal:  Microbes Infect       Date:  2019-09-28       Impact factor: 2.700

Review 2.  Hacking the host: exploitation of macrophage polarization by intracellular bacterial pathogens.

Authors:  Joseph D Thiriot; Yazmin B Martinez-Martinez; Janice J Endsley; Alfredo G Torres
Journal:  Pathog Dis       Date:  2020-02-01       Impact factor: 3.166

3.  Coxiella burnetii Intratracheal Aerosol Infection Model in Mice, Guinea Pigs, and Nonhuman Primates.

Authors:  A E Gregory; E J van Schaik; K E Russell-Lodrigue; A P Fratzke; J E Samuel
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

4.  Mechanisms of action of Coxiella burnetii effectors inferred from host-pathogen protein interactions.

Authors:  Anders Wallqvist; Hao Wang; Nela Zavaljevski; Vesna Memišević; Keehwan Kwon; Rembert Pieper; Seesandra V Rajagopala; Jaques Reifman
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

5.  Robust growth of avirulent phase II Coxiella burnetii in bone marrow-derived murine macrophages.

Authors:  Diane C Cockrell; Carrie M Long; Shelly J Robertson; Jeffrey G Shannon; Heather E Miller; Lara Myers; Charles L Larson; Tregei Starr; Paul A Beare; Robert A Heinzen
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

6.  Interaction between autophagic vesicles and the Coxiella-containing vacuole requires CLTC (clathrin heavy chain).

Authors:  Eleanor A Latomanski; Hayley J Newton
Journal:  Autophagy       Date:  2018-07-29       Impact factor: 16.016

7.  The Role of Alveolar Macrophages in the Improved Protection against Respiratory Syncytial Virus and Pneumococcal Superinfection Induced by the Peptidoglycan of Lactobacillus rhamnosus CRL1505.

Authors:  Patricia Clua; Mikado Tomokiyo; Fernanda Raya Tonetti; Md Aminul Islam; Valeria García Castillo; Guillermo Marcial; Susana Salva; Susana Alvarez; Hideki Takahashi; Shoichiro Kurata; Haruki Kitazawa; Julio Villena
Journal:  Cells       Date:  2020-07-09       Impact factor: 6.600

8.  MyD88 Is Required for Efficient Control of Coxiella burnetii Infection and Dissemination.

Authors:  Lisa Kohl; Inaya Hayek; Christoph Daniel; Jan Schulze-Lührmann; Barbara Bodendorfer; Anja Lührmann; Roland Lang
Journal:  Front Immunol       Date:  2019-02-08       Impact factor: 7.561

9.  Alveolar Macrophages Are Key Players in the Modulation of the Respiratory Antiviral Immunity Induced by Orally Administered Lacticaseibacillus rhamnosus CRL1505.

Authors:  Valeria Garcia-Castillo; Mikado Tomokiyo; Fernanda Raya Tonetti; Md Aminul Islam; Hideki Takahashi; Haruki Kitazawa; Julio Villena
Journal:  Front Immunol       Date:  2020-09-29       Impact factor: 7.561

10.  Interaction of Coxiella burnetii Strains of Different Sources and Genotypes with Bovine and Human Monocyte-Derived Macrophages.

Authors:  Katharina Sobotta; Kirstin Hillarius; Pablo H Jiménez; Katharina Kerner; Carsten Heydel; Christian Menge
Journal:  Front Cell Infect Microbiol       Date:  2018-01-12       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.